ID: ALA3663577

Max Phase: Preclinical

Molecular Formula: C23H21F3N4O2

Molecular Weight: 442.44

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cccc(C(=O)N2C3CCC2C(Nc2ccc(C(F)(F)F)cn2)C3)c1-c1ncco1

Standard InChI:  InChI=1S/C23H21F3N4O2/c1-13-3-2-4-16(20(13)21-27-9-10-32-21)22(31)30-15-6-7-18(30)17(11-15)29-19-8-5-14(12-28-19)23(24,25)26/h2-5,8-10,12,15,17-18H,6-7,11H2,1H3,(H,28,29)

Standard InChI Key:  UHZOJHWKZIPNJN-UHFFFAOYSA-N

Associated Targets(Human)

Orexin receptor 2 5902 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Orexin receptor 1 5435 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Orexin receptor 1 669 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 442.44Molecular Weight (Monoisotopic): 442.1617AlogP: 4.92#Rotatable Bonds: 4
Polar Surface Area: 71.26Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.41CX LogP: 3.75CX LogD: 3.75
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.62Np Likeness Score: -0.93

References

1.  (2015)  Substituted 7-azabicyles and their use as orexin receptor modulators, 
2.  (2016)  Substituted 7-azabicycles and their use as orexin receptor modulators, 

Source

Source(1):